Drug maker Aurobindo Pharma Ltd today announced a consolidated net profit of Rs 41.80 crore for the third quarter ended December 31, 2008, marginally lower than the corresponding period a year ago.
The company had a consolidated net profit of Rs 44.57 crore in the same quarter previous year, Aurobindo Pharma said in a filing to the Bombay Stock Exchange.
Its consolidated net income rose to Rs 882.82 crore for the quarter under review from Rs 572.38 crore for the December quarter previous financial year.
For the nine months ended December 31, 2008, its consolidated net profit dropped to Rs 19.85 crore from Rs 168.37 crore for the same period last year.
The consolidated income for the nine month period under review increased to Rs 2,215.51 crore from Rs 1,738.21 crore in the same period a year ago.
Its standalone net profit dropped to Rs 40.72 crore in the December quarter 2008 from Rs 55.25 crore in the same period previous year.
The standalone net income increased to Rs 722.17 crore during the third quarter in review from Rs 538.93 crore in December quarter of 2007.
For the nine months ended December 31, 2008, the firm & a poss standalone net profit declined to Rs 42.09 crore from Rs 214.70 crore for the same period last year.